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Dexamethasone inhibits S. aureus-
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Pathogen-Killing Mechanism, 
Possibly through Toll-like  
receptor regulation
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Neutrophils release neutrophil extracellular traps (NETs) in a pathogen-killing process 
called NETosis. Excessive NETs formation, however, is implicated in disease patho-
genesis. Therefore, to understand how NETosis is regulated, we examined the effect 
of dexamethasone (DXM), an anti-inflammatory drug, on this process and the role of 
toll-like receptors (TLRs). We stimulated human neutrophils with phorbol 12-myristate 
13-acetate (PMA) or Staphylococcus aureus (S. aureus) and quantified NETs formation. 
We also examined the effect of DXM on the bactericidal effect of NETs and the role of 
reactive oxygen species (ROS) and nuclear factor (NF)-κB in DXM-regulated NETosis. 
DXM significantly inhibited S. aureus-induced NETosis and extracellular bacterial killing. 
ROS production and NF-κB activation were not involved in DXM-regulated NETosis. 
TLR2 and TLR4, but not TLR5 or TLR6, modified S. aureus-induced NETs formation. 
Neither DXM nor TLRs were involved in PMA-induced NETosis. Furthermore, TLR2 and 
TLR4 agonists rescued DXM-inhibited NETosis, and neither TLR2 nor TLR4 antagonists 
could further inhibit NETosis reduction induced by DXM, indicating that DXM may inhibit 
NETosis by regulating TLR2 and TLR4. In conclusion, the mechanisms of S. aureus- 
and PMA-induced NETosis are different. DXM decreases NETs formation independently 
of oxidant production and NF-κB phosphorylation and possibly via a TLR-dependent 
mechanism.
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inTrODUcTiOn
Neutrophils are the most abundant leukocytes in human blood and play an essential role in innate 
immunity since they are the first cells recruited to sites of infection and inflammation (1). They 
engulf microorganisms or opsonized particles and degrade them intracellularly as well as releasing 
microbicidal proteins and reactive oxygen species (ROS) (2). Recently, these cells have been shown 
to release structures called neutrophil extracellular traps (NETs), which consist of chromatin along 
with histones and many granular antimicrobial proteins—including elastase, myeloperoxidase, and 
calprotectin; this is a novel extracellular pathogen-killing mechanism described as NETosis (3–5).
2Wan et al. Dexamethasone Inhibits S. aureus Induced NETosis
Frontiers in Immunology | www.frontiersin.org February 2017 | Volume 8 | Article 60
Although NETosis contributes to pathogen control, it is 
essential for the balance between the formation and removal 
of NETs to be regulated to ensure tissue homeostasis, because 
large amounts of NETs may contribute to collateral damage 
within inflamed tissues. Excessive amounts of NETs are associ-
ated with the pathogenesis of inflammatory and autoimmune 
diseases, including preeclampsia (6), cystic fibrosis (7), and 
lupus (8). Moreover, NETs have been observed to act as a scaf-
fold for thrombus formation (9, 10), which is increasingly being 
recognized as a critical phenomenon linking inflammation 
with venous thrombosis. Therefore, NETosis is a double-edged 
sword: while it is an effective first-line antimicrobial mechanism, 
it might also lead to organ failure and death if it is unregulated. 
Hence, it is important to understand the mechanism of NETs 
regulation, but little information is available about this topic 
thus far.
Since an inflammatory microenvironment is essential for 
NETs formation, we believed that using glucocorticoids, which 
are potent anti-inflammatory drugs, can help elucidate how 
NETs formation is regulated. They are commonly used to resolve 
inflammation and are closely related to neutrophil function. They 
have been shown to inhibit neutrophil apoptosis and cytokine 
release during inflammation (11) and are also associated with 
many neutrophil functions, including chemotaxis, migration, 
and phagocytosis (12). Therefore, we examined the effect of a 
commonly used glucocorticoid drug, dexamethasone (DXM), on 
NETs formation. On the other hand, toll-like receptors (TLRs), 
which are essential pattern-recognizing receptors (PRRs) that 
mediate the recognition of microbial structures, have been 
reported to activate neutrophil extracellular traps to ensnare 
bacteria in septic blood (13). Moreover, most of the TLRs were 
reported to be expressed in neutrophils and were involved in 
neutrophils activation (14). So, we also investigated the role of 
different TLRs in NETs formation.
We found that DXM significantly inhibited NETs formation 
induced by Staphylococcus aureus (S. aureus) but not that induced 
by phorbol 12-myristate 13-acetate (PMA), which suggested 
that DXM can serve as a potential drug to regulate NETosis. In 
addition, the modulation of TLR-2 and TLR4 had an effect on 




Phorbol 12-myristate 13-acetate, DXM, DNase I, cytochalasin D, 
and dichlorofluorescein diacetate (DCF-DA) were purchased from 
Sigma-Aldrich (St. Louis, MO, USA); Percoll, from GE Healthcare 
(Little Chalfont, UK); and TLR agonists and TLR antagonists, 
from InvivoGen (San Diego, CA, USA). Anti-histone H2B and 
neutrophil elastase antibodies, anti-glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) antibody, anti-phosphorylated nuclear 
factor κB (anti-p-NF-κB, p65) antibody, secondary antibod-
ies coupled to AF488 or AF555, and horseradish peroxidase 
(HRP) secondary antibody were purchased from Santa Cruz 
Biotechnology (CA, USA). SYTOX Green, Luria broth, Quant-iT 
PicoGreen double-stranded deoxyribonucleic acid (dsDNA) 
assay kit and micro-plates were purchased from ThermoFisher 
Scientific (Basingstoke, UK).
isolation of human neutrophils
Neutrophils were isolated from the peripheral blood of fasting 
healthy donors by Percoll gradient centrifugation, as previously 
described (7). For those donors, comprehensive history and physi-
cal examination were performed, basic laboratory tests were used 
to exclude occult disease. This study was conducted according to 
the principles expressed in the Declaration of Helsinki. Ethical 
approval was obtained from the Ethics Committee of Affiliated 
Second Hospital, School of Medicine, Zhejiang University, China. 
All participants provided written informed consent for the col-
lection of samples and subsequent analyses. For each donor, 
10–30  ml blood was drawn according to the need of different 
assays. Bloods from at least three donors were used to repeat the 
same assay. Cell suspensions contained >96% neutrophils, as 
determined by Wright–Giemsa staining, with 98% cell viability 
as determined by Trypan blue staining. The cells (4 ×  105/ml) 
were re-suspended in RPMI 1640 medium supplemented with 
bovine serum albumin (2%).
neutrophils stimulation
Neutrophils (2 × 105 cells/well in 500 µl) were stimulated with 
PMA (50  nM) or S. aureus (multiplicity of infection =  10) 
and placed in a humidified incubator at 37°C with CO2 (5%) 
for 120  min. In some experiments, neutrophils were first 
incubated for 120  min with DXM (10  µM), TLR2 agonist 
(HKLM, 108  CFU/ml), TLR4 agonist (LPS, 1  µg/ml), TLR5 
agonist (FSL-ST, 1 µg/ml), TLR6 agonist (FSL-1, 1 µg/ml), TLR 
neutralizing antibodies as antagonists (TLR2, 4, 5, 6 antibody, 
1 µg/ml), or vehicle (controls). Stock solutions of DXM, TLR 
agonists, and TLR antagonists were prepared in DMSO and 
were further diluted in RPMI 1640 medium. The final DMSO 
concentration (0.1% v/v) did not have a toxic effect. All drugs 
were freshly prepared for each experiment.
neTs Formation assay
After stimulation, cells were fixed with 4% PFA, blocked with 3% 
normal donkey serum and 0.05% Tween 20 in phosphate-buffered 
saline (PBS), and incubated with the primary antibodies anti-H2B 
and anti-neutrophil elastase, which were detected with secondary 
antibodies coupled to AF488 or AF555. Isotype-matched controls 
were used. For DNA detection, 4′, 6′-diamidino-2-phenylindole 
(DAPI) was used. Specimens were mounted and analyzed under 
a confocal microscope (Olympus IX-50).
Neutrophil extracellular traps were also examined using 
the membrane-impermeable DNA-binding dye SYTOX green 
(Molecular Probes, Invitrogen Life Technologies). SYTOX 
green (5 µM) was added to the cultures after specific periods of 
incubation, and the cultures observed 5 min later. In one case, 
DNase I (100 U/ml) was added for 10 min to degrade the NETs 
structure as control. To visualize NETs, live-cell cultures were 
imaged with an inverted fluorescence microscope (Olympus 
IX-50).
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Bacterial culture
Staphylococcus aureus (ATCC 25923) was cultured overnight 
in Luria–Bertani (LB) broth (37°C, 200  rpm), harvested by 
centrifugation, washed, and suspended in PBS. Bacterial growth 
was quantified at A600 and the cell number determined using a 
standard curve based on colony counts. Stationary-phase bacteria 
were used for all experiments.
Quantification of extracellular Dna
The levels of extracellular DNA in supernatants were quantified 
using Quant-iT PicoGreen dsDNA assay kit according to the 
manufacturer’s instructions. PicoGreen is a cell-impermeable 
dye that binds to extracellular dsDNA without staining live 
cells. Fluorescence intensity was measured on a SpectraMax M3 
(Molecular Devices) fluorescent plate reader at an excitation 
wavelength of 480 nm and an emission wavelength of 520 nm, 
with a 515-nm emission cutoff filter. The calibration curve was 
constructed using a standard dsDNA of a known concentration.
Bacterial survival assay of neTs
A bacterial survival assay was performed as described in earlier 
studies (15). Neutrophils (1 × 106 cells/well in 200 µl) were pre-
incubated with or without DXM for 2 h and then treated with 
50  nM PMA or left untreated for another 2  h at 37°C and 5% 
CO2. NETs killing was examined by inhibiting phagocytic killing 
by the addition of 100 µg/ml cytochalasin D for 15 min before the 
addition of bacteria. After 1 h at 37°C, neutrophils and clumped 
NETs were disrupted by the addition of 0.01% Triton X-100 and 
three passes through a 25-gauge needle. Following serial dilution, 
bacteria were plated on LB plates for colony counting. After over-
night incubation at 37°C, the number of colony-forming units 
(CFU) was determined. Zero killing was defined by control sam-
ples consisting of RPMI 1640. Killing efficacy was determined by 
subtracting the CFU of indicated treatment from control group.
rOs Production
Neutrophils were incubated in PBS (Ca2+- and Mg2+-free) with 
10 µM DCF-DA (Sigma) at 37°C for 20 min. Subsequently, they 
were pelleted, washed in PBS three times, and transferred to a 
96-well plate (1 × 106 cells/well in 100 µl). They were then stimu-
lated with S. aureus for 1 h (some cells were pretreated with DXM 
for 120 min), and fluorescence was measured using SpectraMax 
M3 fluorescent plate reader at an excitation wavelength of 480 nm 
and an emission wavelength of 520 nm.
immunoblotting
The neutrophils (3 × 106 cells/well in 500 µl) were pre-incubated 
with or without DXM for 2 h and then stimulated for another 
2 h with S. aureus. Cell lysates were prepared using 1× loading 
buffer and boiled. Samples were then frozen at −80°C until use. 
Equal amounts of proteins were run on 12% sodium dodecyl 
sulphate-polyacrylamide gel and then electrotransferred onto 
polyvinylidenefluoride membranes. After blocking with 5% 
bovine serum albumin, membranes were incubated with 
phospho-NF-κBp65 and anti-GAPDH antibody overnight at 
4°C, and then with HRP-conjugated secondary antibody for 2 h 
at room temperature. Protein bands were visualized by enhanced 
chemiluminescence. The gray degree of protein bands was 
detected by image J, and the value of p-NF-κB p65/GAPDH was 
calculated.
statistical analysis
Statistical analyses were performed using GraphPad Prism 6.1. 
Data are expressed as mean ±  SE of individual samples. For 
two-group comparison, Student’s t-test was applied for normally 
distributed data. The comparisons between multiple groups were 
performed using one-way ANOVA, followed by a Bonferroni’s 
post-test. The significance threshold was set at 0.05.
resUlTs
neTs Formation in response to PMa and 
Bacterial stimulation
Microscopic observation clearly showed NETs structure, includ-
ing neutrophil-derived proteins. Neutrophils were labeled with 
DAPI to identify DNA (blue) and with antibodies to identify 
neutrophil histone (green) and elastase (red) (Figure 1A). This 
confirmed PMA- or S. aureus-triggered NETs formation. SYTOX 
green staining further showed that bacteria were trapped in the 
web like structure and could be released when this NETs forma-
tion was degraded by Dnase I (Figure 1B).
DXM inhibits neTs Formation induced by 
S. aureus But not That induced by PMa
Fluorescence microscopy showed that DXM did not have any 
effect on the NETs formation induced by PMA but markedly 
inhibited that induced by S. aureus (Figure  2A). To further 
corroborate these, NETs formation was measured by quantify-
ing the extracellular DNA in the supernatants. This experiment 
confirmed that S. aureus-induced formation of extracellular traps 
was significantly decreased by DXM (p < 0.05). In contrast, the 
amount of NETs formed after PMA induction was similar in 
controls and in DXM-treated neutrophils (p > 0.05) (Figure 2B). 
In addition, DMSO (0.1% v/v) in the solution of stimulates had 
no effect on NETs formation.
DXM Decreases the Bactericidal efficacy 
of neTs
Dexamethasone significantly decreased the bactericidal efficacy 
of NETs, following abrogating phagocytic killing by the addition 
of cytochalasin D (p < 0.05; Figure 3). However, if neutrophils 
were activated to form NETs by PMA, DXM treatment had no 
effect on the killing efficacy of NETs (p > 0.05).
rOs and nF-κB activation are not 
involved in DXM-regulated neTosis
Reactive oxygen species generation was first evaluated in rest-
ing neutrophils by performing a DCF-DA fluorescence assay. 
DCF-DA is a non-fluorescent molecule that becomes fluorescent 
in the presence of a wide variety of ROS, including superoxide 
anion and hydroxyl radicals (16). NETs formation has previ-
ously been reported to be dependent on or independent of ROS 
(17). In order to examine if DXM-regulated NETs formation is 
FigUre 1 | Phorbol 12-myristate 13-acetate (PMa) and Staphylococcus aureus (S. aureus) stimulate neutrophil extracellular traps (neTs) formation 
in human neutrophil. Human neutrophil suspended in media were treated with PMA (50 nM) or S. aureus at MOI of 10. Human neutrophil without treatment (N) 
was used as control. NETs formation was measured at 2 h. (a) Neutrophils were labelled with 4′, 6′-diamidino-2-phenylindole (DAPI) to identify DNA (blue) and with 
antibodies to identify neutrophil histone (green) and elastase (red). PMA and S. aureus-induced NETs formation. (B) S. aureus (indicated with arrow) were trapped in 
NETs and released when NETs structure was degraded by DNase I, as observed by SYTOX green staining Bar: 50 μm.
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FigUre 2 | Dexamethasone (DXM) inhibited neutrophil extracellular traps (neTs) formation induced by Staphylococcus aureus (S. aureus) but not 
that induced by phorbol 12-myristate 13-acetate (PMa). Human neutrophils suspended in media were pretreated with or without DXM (10 µM) for 2 h, and 
then NETs formation 2 h after stimulation with PMA or S. aureus was examined using the membrane-impermeable DNA-binding dye SYTOX green and quantified by 
Quant-iTPicoGreen double-stranded deoxyribonucleic acid assay kit. Neutrophils without any stimulation or treated with DMSO (0.1% v/v) were used as control.  
(a) DMSO (0.1% v/v) did not affect NETs formation. While dexamethasone did not modify NETs formation induced by PMA, it markedly inhibited that induced by S. 
aureus. Several typical NETs were indicated with arrows. Bar: 50 μm. (B) Quantification of extracellular DNA confirmed that it inhibited NETs formation induced by S. 
aureus but not that induced by PMA. Neutrophils (1 × 105cells/well in 100 µl) were stimulated to form NETs, and the mean value of NETs amount in five replicated 
wells was adopted. The assay was repeated for three times with bloods from three different donors; error bars represent SEM. *p < 0.05 by ANOVA with 
Bonferroni’s post-test.
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FigUre 3 | Dexamethasone (DXM) inhibited the bactericidal efficacy 
of neutrophil extracellular traps (neTs). Neutrophils were pre-incubated 
with or without DXM for 2 h and then treated with 50 nM phorbol 
12-myristate 13-acetate (PMA) or left untreated for another 2 h. One hour 
after addition of bacteria, colony-forming units (CFU) were determined by 
overnight incubation at 37°C following serial dilution. Zero killing was defined 
by control samples consisting of only media. Killing efficacy was determined 
by subtracting the CFU of indicated treatment from control groups. By using 
cytochalasin D to abrogate phagocytic killing, dexamethasone was found to 
significantly inhibit the bactericidal efficacy of NETs. However, 
dexamethasone could not inhibit PMA-activated bactericidal efficacy of NETs. 
The assay was repeated for nine times, each case in three wells; error bars 
represent SEM. *p < 0.05 by ANOVA with Bonferroni’s post-test.
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ROS-dependent, ROS production by activated neutrophils with 
or without DXM stimulation was measured. S. aureus infection 
elicited significant neutrophil oxidative burst, but DXM treat-
ment neither increased nor decreased this response noticeably 
(Figure 4A).
The transcription factor NF-κB is a key regulator of inflamma-
tion and therefore plays a pivotal role in a wide range of inflam-
matory diseases (18). The phosphorylation of NF-κB has been 
believed to be involved in NETs generation (19). Therefore, we 
explored the role of DXM in the activation of NF-κB induced by S. 
aureus. The expression of p-NF-κB (p65) was significantly higher 
when the cells were stimulated with S. aureus, but this effect was 
not modified by DXM (Figures 4B,C).
Tlrs are involved in neTs Formation 
induced by S. aureus But not That 
induced by PMa
Toll-like receptors are key PRRs, which are important in innate 
immune responses. Thus, we explored the role of TLRs in 
the formation of NETs. None of TLR2 agonist, TLR4 agonist, 
TLR5 agonist, and TLR6 agonist could induce NETs formation. 
However, TLR2 and TLR4 agonists significantly enhanced NETs 
formation induced by S. aureus but not that induced by PMA, 
as shown by the quantification of extracellular DNA. Moreover, 
blocking TLR2 and TLR4 with neutralizing antibodies 
significantly reduced the NETs formation induced by S. aureus 
but not that induced by PMA, as shown by quantification of 
extracellular DNA (Figure 5). Furthermore, neither the TLR5/
TLR6 agonist nor the antagonist could modulate the formation 
of NETs.
DXM May Modulate S. aureus-induced 
neTs Formation through Tlr2 and Tlr4
To explore the mechanism of DXM-modulated NETs formation, 
we first pre-incubated the cells with TLR agonists to examine the 
effect of TLRs on DXM-inhibited NETs formation. As expected, 
both HKLM (TLR2 agonist) and LPS (TLR4 agonist) rescued 
DXM-reduced NETs formation (Figure 6A). Moreover, neither 
TLR2 nor TLR4 antagonist could further decrease DXM-induced 
NETosis reduction (Figure 6B). While these findings suggested 
that DXM may modulate S. aureus-induced NETs formation 
through TLR2 and TLR4, further research is required to under-
stand the precise mechanism.
DiscUssiOn
NETosis, a recently identified mechanism of pathogen killing, 
helps in isolating and preventing the spread of invading bacteria, 
but the persistent formation or insufficient degradation of NETs 
can also cause injury to the host (8, 20). Since regulation of NETs 
formation is essential for tissue homeostasis, we aimed to deter-
mine the mechanisms and molecules underlying the regulation 
of this process.
A variety of stimuli promote NETs formation. In our study, 
NETs formation could be induced in neutrophils by both 
pharmacologic (PMA) and pathogenic (bacterial) stimuli, a 
finding that is in agreement with those of previous studies (21, 
22). Although several signaling mechanisms responsible for 
NETs formation have been reported, critical regulatory elements 
remain unidentified. Since the findings from different studies 
often vary, it is possible that more than one mechanism exists. 
In this study, we observed that DXM-inhibited NETs formation 
induced by bacteria but not that induced by PMA. In addition, 
it markedly decreased the bactericidal ability of NETs. Thus far, 
DXM has not been reported to affect NETs formation induced by 
S. aureus. Lapponi reported that treatment of neutrophils with 
DXM had no effect on NETs formation induced by PMA or TNF-
α (19). This is consistent with our observation that DXM was not 
required for the regulation of PMA-induced NETs formation. 
Other studies have suggested that NETs formation induced by 
different stimuli have distinct mechanisms. For example, Riyapa 
et al. (23) reported that when compared to the neutrophils of dia-
betic patients, those of normal individuals produced less PMA-
induced NETs but the same amount of S. aureus-induced NETs. 
Parker et  al. (24) hypothesized that whether NADPH oxidase 
and myeloperoxidase are required in NETs formation depends 
on the stimulus. These results prompted us to investigate whether 
different stimuli indeed have different underlying mechanisms. 
Our findings strongly suggested that bacteria and PMA regulate 
NETs formation through different pathways and that DXM may 
FigUre 4 | activation of reactive oxygen species (rOs) or nuclear factor (nF)-κB was not involved in dexamethasone-regulated neTosis. Neutrophils 
were pretreated with or without dexamethasone (DXM) for 2 h and then stimulated with Staphylococcus aureus (S. aureus) for 1 h. ROS production were 
determined by dichlorofluorescein diacetate fluorescence and NF-κB activation were determined by Western blot. (a) S. aureus infection elicited significant 
neutrophil oxidative burst, but DXM treatment neither increased nor decreased this response. Data represent mean ± SEM of triplicate experiments. (B) NF-κB was 
activated when stimulated with S. aureus but not modified by dexamethasone. (c) Quantification showed that p-NF-κB (p65) expression was significantly higher 
when the cells were stimulated with S. aureus, but this effect was not modified by dexamethasone. Data represent mean ± SEM of triplicate experiments, *p < 0.05 
by Student’s t-test.
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have an effect on NETs formation induced by bacteria but not on 
that induced by PMA.
Neutrophil extracellular traps formation has been shown to 
require NADPH oxidase activity as well as NF-κB activation. Our 
results verified the involvement of NADPH oxidase activity and 
NF-κB activation in the process of NETs formation. However, in 
contrast to our expectation, no change in ROS or pNF-κB levels 
was observed in DXM-treated neutrophils stimulated by S. aureus, 
which indicated that ROS and NF-κB signaling pathways were 
not involved in DXM-regulated NETs formation. NETosis was 
previously reported to be of two types: ROS dependent and ROS 
independent. Our study shows that DXM may modulate ROS-
independent NETosis. Interestingly, DXM has been reported to 
inhibit calcium mobilization, which was shown to increase in 
LPS-treated cells (25). Therefore, DXM may regulate NETosis by 
modulating calcium mobilization, which is ROS independent. 
Moreover, our study showed that the phosphorylation of NF-κB, 
which has been shown to participate in NETs formation (19), 
is not involved in DXM-modulated NETosis. It may be because 
different stimuli were used, with bacteria in ours and PMA in 
others. Nevertheless, as we only detected the phosphorylation 
of NF-κB in whole cell, it could not be excluded that there were 
NF-κB shifting from plasma to nucleus.
The specific detection of microorganisms by innate cells is 
mediated by PRRs—germline-encoded receptors that recog-
nize microbial structures referred to as pathogen-associated 
molecular patterns (26). TLRs are essential PRRs that mediate 
the recognition of microbial structures, such as those of bacteria, 
as well as the subsequent inflammatory and adaptive responses 
(27–30). Because neutrophils and TLRs are, respectively, the 
prototypical cells and receptors involved in innate immune 
responses, the effect of TLRs on NETosis was investigated. Our 
findings suggested that TLRs involved in inflammatory response 
could be key regulatory factors in NETs formation. Our results 
FigUre 5 | Toll-like receptors (Tlrs) were involved in Staphylococcus aureus (S. aureus)-induced but not phorbol 12-myristate 13-acetate 
(PMa)-induced neutrophil extracellular traps (neTs) formation. Neutrophils were pretreated with TLRs agonist or antagonist, followed by PMA or S. aureus 
stimulation. NETs formation was quantified by Quant-iT PicoGreen double-stranded deoxyribonucleic acid assay kit. (a) None of TLR2 agonist (HKLM), TLR4 
agonist (LPS), TLR5 agonist (FSL-ST), and TLR6 (FSL-1) agonist could induce NETs formation. (B) Treatment with TLR2 agonist (HKLM) and TLR4 agonists (LPS) 
significantly enhanced NETosis, and blocking TLR2 and TLR4 with neutralizing antibodies significantly reduced S. aureus-induced NETs formation. None of TLR5 
agonist (FSL-ST), TLR6 agonist (FSL-1), and TLR5 and TLR6 neutralizing antibodies was involved in S. aureus-induced NETs formation. (c) TLRs were not involved 
in PMA-induced NETs formation. The assay was repeated for three times, each case in five wells, error bars represent SEM. Compared to S. aureus or PMA 
stimulation, *p < 0.05, ns = p > 0.05 by Student’s t-test.
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showed that S. aureus-induced NETosis was markedly inhibited 
by TLR2 and TLR4 antagonists and enhanced by TLR2 and TLR4 
agonists. This strongly supports the role of TLR2 and TLR4 in 
the biogenesis of NETs, but these effects were not observed in 
PMA-induced NETosis. Furthermore, neither TLR5 nor TLR6 
agonists/antagonists had any effect on bacteria-induced NETosis. 
As TLR2 is the main receptor for Gram positive, and TLR4 is for 
Gram-negative bacteria, respectively, it is reasonable that both 
of them may directly or indirectly participate in the process of 
NETosis triggered by S. aureus through the whole inflammatory 
network. It is further confirmed by the following results. The 
addition of TLR2 and TLR4 agonists (HKLM and LPS) rescued 
DXM-inhibited NETs formation induced by S. aureus, but to a 
lower extent than in the control group stimulated by S. aureus. 
Therefore, we believe that both TLR2 and TLR4 were involved in 
DXM-modulated NETosis, which is consistent with the observa-
tion in other studies that multiple receptors may together regulate 
NETs formation (31). Besides, we were unable to conclude 
whether other TLRs that mediated the interaction of neutrophils 
and other pathogens like viruses could also be involved.
In addition, we aimed to determine the relationship between 
DXM and TLRs. Both HKLM and LPS rescued DXM-reduced 
NETs formation. Moreover, neither TLR2 nor TLR4 antagonist 
could further decrease DXM induced NETosis reduction. This 
indicated the involvement of TLRs in DXM-reduced NETosis. A 
previous study showed that DXM down-regulates TLR4 mRNA 
expression in neutrophils (32), which implies that it may regulate 
NETosis by modulating TLR expression (33).
Our study has a limitation: we examined neutrophil function 
only in vitro; further in vivo studies are needed to characterize 
the fate of neutrophils. It is also not clear how DXM and TLRs 
cooperatively modulate NETs formation. Further research is 
needed to clarify these points.
In conclusion, we have demonstrated that NETs formation 
can be induced in neutrophils by different stimuli but not 
by a common mechanism. The mechanism of how DXM 
modulates bacteria-induced NETs formation was found to 
be unrelated to oxidant production and phosphorylation of 
NF-κB. TLR2 and TLR4 are involved in the formation of NETs. 
Although the specific mechanisms of how DXM regulates 
FigUre 6 | Dexamethasone (DXM) may modulate Staphylococcus aureus (S. aureus)-induced neutrophil extracellular traps (neTs) formation 
through toll-like receptor (Tlr)2 and Tlr4. (a) Neutrophils were pretreated with HKLM (TLR2 agonist) and LPS (TLR4 agonist), followed by DXM treatment and 
S. aureus stimulation. NETs formation was quantified by Quant-iTPicoGreen double-stranded deoxyribonucleic acid (dsDNA) assay kit. Both HKLM and LPS 
rescued dexamethasone-reduced NETs formation. (B) Neutrophils were pretreated with TLR2 and TLR4 antagonist, followed by DXM treatment and S. aureus 
stimulation. NETs formation was quantified by Quant-iTPicoGreen dsDNA assay kit. Neither TLR2 nor TLR4 antagonist could further decrease DXM induced NETosis 
reduction. The assay was repeated for three times, each case in five wells, error bars represent SEM. *p < 0.05 by Student’s t-test.
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NETs formation are unclear, it is possible that DXM regulates 
NET formation induced by S. aureus via a TLR-dependent 
mechanism.
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